| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |